Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Increased antitumor effects of bevacizumab plus 5-FU/leucovorin in colorectal cancer

Feb. 26, 2003

AVI-4126 increases sensitivity of lung tumors to conventional chemotherapeutic agents

Feb. 25, 2003

SB-203580 induces p38 MAP kinase-independent differentiation of leukemia cells

Feb. 25, 2003

Ono-4817 plus docetaxel inhibits lung micrometastasis of MMP-expressing tumor cells in nude mice

Feb. 25, 2003

Enrollment temporarily suspended in phase III studies of tariquidar

Feb. 25, 2003

Advexin awarded orphan drug designation

Feb. 25, 2003

Alphav integrin antagonists and their use disclosed by 3DP

Feb. 25, 2003

Vertex scientists design novel inhibitors of Src and/or Lck kinases

Feb. 25, 2003

Novel HGF receptor tyrosine kinase inhibitors described by Kirin Brewery

Feb. 24, 2003

New distribution agreements for Foscan in East Europe and Mediterranean

Feb. 21, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...